Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201201112 Principal Investigator: Lockhart, A. Craig
Title: A Phase 1 First-in-Human Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 172 in Subjects with Relapsed / Refractory Renal Cell Carcinoma
Phase: I Disease Site: Kidney
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research study is to find out more about a study drug called AMG 172 in people with kidney cancer. The study will see if AMG 172 is safe in people who are 18 years of age or older and whether it causes any side effects. This study will also look at what doses of AMG 172 are safe for people to take and evaluate the amount of AMG 172 in your blood at various times during the study.
 
More Information:
ClinicalTrials.gov #
Internal Protocol Documents (requires Siteman administrative database password)